Intrapleural cisplatin and OK432 therapy for malignant pleural effusion caused by non‐small cell lung cancer

Abstract

Although chest tube drainage took longer because of the time required for multiple administration of the agents, intrapleural combination therapy with cisplatin and OK432 was more effective in controlling malignant pleural effusions due to non-small cell lung cancer than monotherapy with either agent.